Generating mutated proteins through adversarial attacks on the AlphaFold2 model

Announcing a new publication for Acta Materia Medica journal. Proteins are essential macromolecules that perform functions according to their conformational dynamics.

WM Technology Q2 Revenue Bounces to $50.9 Million

WM Technology, Inc. Reports Second Quarter 2023 Financial Results Announces Second Quarter 2023 Financial Results with Revenue of $50.9 million, Net Income of $2.0 million

August 9, 2023

Third JAK Inhibitor for Alopecia Areata Wins FDA Approval

The FDA approved the oral Janus kinase (JAK) inhibitor deuruxolitinib (Leqselvi) to treat alopecia areata, drugmaker Sun Pharmaceutical announced on Thursday. The approval stipulates use

July 27, 2024

Stem-Cell Mobilization Booster Wins FDA Approval for Multiple Myeloma

The FDA has approved the CXCR4 antagonist motixafortide (Aphexda) for use with filgrastim (Neupogen) to mobilize stem cells for autologous transplantation in multiple myeloma, BioLineRx

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.